Showing results (481-490 of 966) with videos related to

Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|February 23, 2026
Innovative approaches for lung cancer screening and interceptionJianjun Zhang, Matthew D Park, Tej Pandya, et al.
Nature Reviews. Clinical Oncology|February 20, 2026
Evolving roles of liquid biopsy in precision medicine for colorectal cancer: from single-gene analysis to broad genomic profilingGiulia Martini, Stefania Napolitano, Davide Ciardiello, et al.
Nature Reviews. Clinical Oncology|March 3, 2026
Perioperative approaches for patients with biliary tract cancerAnudari Zorigtbaatar, Zhihao Li, Christian T J Magyar, et al.
Nature Reviews. Clinical Oncology|April 10, 2024
Antiangiogenic-immune-checkpoint inhibitor combinations: lessons from phase III clinical trialsHung-Yang Kuo, Kabir A Khan, Robert S Kerbel
Nature Reviews. Clinical Oncology|October 16, 2023
Molecular tumour boards - current and future considerations for precision oncologyApostolia M Tsimberidou, Michael Kahle, Henry Hiep Vo, et al.
Nature Reviews. Clinical Oncology|May 5, 2026
The transformative role of SBRT in the management of spinal metastasesK Liang Zeng, Pejman Jabehdar Maralani, Michael Hardisty, et al.
Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.
Nature Reviews. Clinical Oncology|June 17, 2026
Antibody-drug conjugates in gynaecological cancers: opportunities and challengesKathleen N Moore, Oladapo O Yeku, Brooke E Howitt, et al.
Nature Reviews. Clinical Oncology|January 11, 2012
Equipoise: asking the right questions for clinical trial designSteven Joffe, Franklin G Miller
Nature Reviews. Clinical Oncology|July 9, 2026
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeuticsSamuel Grigg, Carolyn Shembrey, Mohamed Fareh, et al.
Pageof 97